This section presents the latest developments, inventions, and revolutionary technologies that change the face of healthcare.
ExtriCARE USA has introduced its revolutionary extriCARE 3000 pump, with US FDA approval in the USA. Patients can anticipate receiving the best care possible and medical professionals now have access to a potent tool for controlling wounds....
Stryker introduces SmartMedic, a new patient care platform that improves hospital ICU bed functionality....
Neuro20 PRO System, a first-of-its-kind wearable has been discovered by Neuro20 Technologies Corp.The Neuro20 PRO System is a system that is designed to help with both strength and recovery. It has four different programs and nine sub-modes that can be used for this purpose....
Bioretec has recently developed a new type of metal implant, called RemeOs™ trauma screw, which is designed to help in the healing of bone fractures....
The new SCOUT® MD™ Surgical Guidance System has been given a breakthrough device designation by the US Food and Drug Administration. The SCOUT MD represents the most recent development in Merit's ongoing leadership and dedication to improving oncology care. The SCOUT® Radar Localization system with the new SCOUT® Mini Reflector and SCOUT Bx...
Onward Medical has unveiled a non-invasive wireless stimulator for bladder control, spasticity relief, and blood pressure management for people with spinal cord injuries. (SCI). The U.S. Food and Drug Administration (FDA) has granted this novel innovation as a breakthrough device. An external, non-invasive device called ARC-EX functions as a wireless...
RefleXion Medical's SCINTIX biology-guided radiotherapy has been given FDA marketing clearance, for the treatment of early-stage and late-stage cancers. With SCINTIX radiotherapy, the location and dose of radiation to be administered during real treatment delivery are autonomously chosen by each cancer's unique biology....
In accordance with the European Union's (EU) In Vitro Diagnostic Medical Devices Regulation (IVDR), Ibex Medical Analytics' Galen™ Prostate pathology diagnostics platform has obtained the CE mark. The novel platform was created to help pathologists in making a preliminary prostate biopsy diagnosis....
Guerbet announced the commercial launch and dosing of the first patient with Elucirem™ (gadopiclenol) injection, following FDA approval in September 2022. It is recommended for use in adults and children 2 years of age and higher. This highly stable macrocyclic gadolinium-based contrast agent...
The FDA granted 510(k) approval to Pristine Surgical for Summit, a first-of-its-kind 4K single-use surgical arthroscope intended to increase the effectiveness, reliability, and security of arthroscopic procedures. With a device that is always new and never out-of-date, Summit combines a 4K single-use surgical arthroscope with cloud-based software called Pristine Connect™ to give a high-definition...
